Bio-Techne Corp
(NAS:TECH)
$
72.14
+0.040 (+0.06%)
Market Cap: 11.24 Bil
Enterprise Value: 11.32 Bil
PE Ratio: 104.55
PB Ratio: 5.42
GF Score: 88/100 Bio-Techne Corp at Bank of America Global Healthcare Conference Transcript
May 12, 2026 / 04:20PM GMT
Release Date Price:
$47.42
Michael Ryskin
Bank of America - Analyst
My name is Mike Ryskin. I'm one the Bank of America Life Science Tools and Diagnostics team. And we're excited to be joined by Bio-Techne. We're pleased to host Kim Kelderman, Chief Executive Officer; and Jim Hippel, Chief Financial Officer. Kim, Jim, thanks for being here.
James Hippel
Bio-Techne Corp - Chief Financial Officer, Executive Vice President - Finance
Great. Thanks for having us.
Questions & Answers
Michael Ryskin
Bank of America - Analyst
Format will be a fireside chat, but raise your hand if you've got a burning question. I mean maybe just to kick things off, you recently reported. Any highlights from the quarter. You talk through sort of how it played out relative to expectations? What was a little bit better?
What was a little bit worse?
Kim Kelderman
Bio-Techne Corp - President - Diagnostics and Genomics
Yes. So yes, we reported and printed negative 2% growth for the quarter, and that was
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot